DEDICATED EARLY-STAGE ONCOLOGY EXPERTISE

Our award-winning, specialized early phase oncology team helps emerging and established biopharma, biotech and pharmaceutical companies accelerate the advancement of early phase compounds through clinical testing.

YOUR CANCER THERAPY SHOWS PROMISE. GET ON YOUR WAY TO FDA APPROVAL FASTER AND EASIER WITH WORLDWIDE.

Oncology research is becoming more competitive, and trial designs are increasing in complexity. Recent reports indicate that the success rate of investigational compounds approved for clinical use in cancer is the lowest among all diseases, and the likelihood of approval for investigational oncology drugs tested in Phase I trials is only 6.7 percent. Who can you trust to help you with your development journey?

YOU’RE MORE THAN A MOLECULE TO WORLDWIDE.

OUR MEDICAL, SCIENTIFIC AND OPERATIONS EXPERTS TAKE YOUR CHALLENGE PERSONALLY.

With Worldwide, you get the best of both worlds: A specialized CRO with global coverage. We’re a full-service, midsized CRO with therapeutic experts who have earned reputations for taking on the most complex and challenging cancer research studies. We offer a global footprint – without the hefty price tag and cookie-cutter approach you get from large, consolidating CROs.